Dyslipidemia, especially a circulating non-optimal level of cholesterol, is one of the most important risk factors for atherosclerotic cardiovascular disease (ASCVD), which accounts for the most deaths worldwide. Maintaining a healthy level of blood cholesterol is an important prevention strategy for ASCVD, through lifestyle intervention or cholesterol-lowering therapy. Over the past three decades, the epidemiology and management of dyslipidemia has changed greatly in many countries. Therefore, it is necessary to understand the current epidemiologic features of dyslipidemia and challenges from a global perspective.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Liu, T., Zhao, D., & Qi, Y. (2022, November 1). Global Trends in the Epidemiology and Management of Dyslipidemia. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm11216377